BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3606146)

  • 1. [Analysis of bladder cancer-associated antigens and their application to diagnosis].
    Masuko T; Hashimoto Y
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2191-7. PubMed ID: 3606146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human bladder cancer cell-surface antigens recognized by murine monoclonal antibodies raised against T24 bladder cancer cells.
    Masuko T; Abe J; Yagita H; Hashimoto Y
    Jpn J Cancer Res; 1985 May; 76(5):386-94. PubMed ID: 3924712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and characterization of mouse monoclonal antibodies to human bladder tumor-associated antigens.
    Young DA; Prout GR; Lin CW
    Cancer Res; 1985 Sep; 45(9):4439-46. PubMed ID: 3896480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies to cell surface antigens shared by chemically induced mouse bladder carcinomas.
    Hellström I; Hellström KE; Rollins N; Lee VK; Hudkins KL; Nepom GT
    Cancer Res; 1985 May; 45(5):2210-8. PubMed ID: 3986770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies against cell surface antigens present on human urinary bladder cancer cells.
    Masuko T; Yagita H; Hashimoto Y
    J Natl Cancer Inst; 1984 Mar; 72(3):523-30. PubMed ID: 6583438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
    Tong AW; Lee J; Stone MJ
    Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies against carcinoma cells of the human urinary bladder: immunohistochemical staining of tissues.
    Ben-Aïssa H; Paulie S; Koho H; Biberfeld P; Hansson Y; Braesch-Andersen S; Lagerkvist M; Lundblad ML; Gustafson H; Perlmann P
    Anticancer Res; 1986; 6(2):165-70. PubMed ID: 2423013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
    Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
    Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monoclonal antibodies against transitional cell carcinoma assay tumor associated antigens in different grades bladder cancer patients].
    Zhang H; Zhao Z; Sun H
    Zhonghua Wai Ke Za Zhi; 1996 Sep; 34(9):560-2. PubMed ID: 9594163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies.
    Metzgar RS; Gaillard MT; Levine SJ; Tuck FL; Bossen EH; Borowitz MJ
    Cancer Res; 1982 Feb; 42(2):601-8. PubMed ID: 7034925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human transitional cell carcinoma in the NMRI-nu/nu mouse bladder: a new animal model for the in vivo use of monoclonal antibodies and cytotoxic agents.
    Huland E; Arndt R; Huland H
    Cancer Res; 1986 May; 46(5):2488-9. PubMed ID: 3697989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification by monoclonal antibodies of an antigen shed by human bladder cancer cells.
    Liebert M; Wedemeyer GA; Stein JA; Washington RW; Flint A; Ren LQ; Grossman HB
    Cancer Res; 1989 Dec; 49(23):6720-6. PubMed ID: 2479470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monoclonal antibodies against tumor associated antigens].
    Masuko T; Hashimoto Y
    Hum Cell; 1988 Mar; 1(1):25-30. PubMed ID: 3154012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
    Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
    Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced detection of bladder cancer in urine cytology with Lewis X, M344 and 19A211 antigens.
    Sagerman PM; Saigo PE; Sheinfeld J; Charitonowics E; Cordon-Cardo C
    Acta Cytol; 1994; 38(4):517-23. PubMed ID: 7913791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical localization of prostate carcinoma-associated antigens.
    Wright GL; Beckett ML; Starling JJ; Schellhammer PF; Sieg SM; Ladaga LE; Poleskic S
    Cancer Res; 1983 Nov; 43(11):5509-16. PubMed ID: 6193873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between serial measurements of the level of a bladder tumor associated antigen and the potential for recurrence.
    Blumenstein BA; Ellis WJ; Ishak LM
    J Urol; 1999 Jan; 161(1):57-60; discussion 60-1. PubMed ID: 10037368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characterization of monoclonal antibody (BIU-H) directed against bladder cancer and its pathologic feature].
    Guo Y
    Zhonghua Yi Xue Za Zhi; 1992 Apr; 72(4):213-5, 254. PubMed ID: 1327448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.